Why counting women is not enough: from inclusion to equity in oncology trials

Nature Reviews Urology · Published 2026-06-16 · DOI 10.1038/s41585-026-01170-7

Authors (4)

David J. Benjamin, Sophie Zaaijer, Shera Feinstein, Arash Rezazadeh Kalebasty

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Citation

Benjamin, D., Zaaijer, S., Feinstein, S., et al. (2026). Why counting women is not enough: from inclusion to equity in oncology trials. Nature Reviews Urology. https://doi.org/10.1038/s41585-026-01170-7

Related articles

• Urolithiasis in patients with cancer · Nature Reviews Urology · 2026 · Same journal
• Bladder cancer research is blossoming in Birmingham · Nature Reviews Urology · 2026 · Same journal
• Animal models of spinal cord injury in neuro-urological research · Nature Reviews Urology · 2026 · Same journal
• Transitional urology: a comprehensive review of the transitional care process · Nature Reviews Urology · 2026 · Same journal
• Polypropylene mesh degradation and systemic disease: biological plausibility is not clinical evidence · Nature Reviews Urology · 2026 · Same journal
• Leveraging generative AI to enhance doctor–patient communication · Nature Reviews Urology · 2026 · Same journal
• Neoadjuvant intraprostatic immunotherapy for high-risk localized prostate cancer · Nature Reviews Urology · 2026 · Same journal
• Implantable pelvic neurostimulators to restore erectile function: from concept to practice · Nature Reviews Urology · 2026 · Same journal
• The clinical utility of prostate MRI before biopsy · Nature Reviews Urology · 2026 · Same journal
• Circulating tumour cells as a window into lethality in prostate cancer · Nature Reviews Urology · 2026 · Same journal